Natural Capsules shines on getting nod to set up subsidiary company

31 Jul 2018 Evaluate

Natural Capsules is currently trading at Rs. 80.05, up by 3.75 points or 4.91% from its previous closing of Rs. 76.30 on the BSE.

The scrip opened at Rs. 79.00 and has touched a high and low of Rs. 80.05 and Rs. 75.00 respectively. So far 470 shares were traded on the counter.

The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 158.90 on 08-Jan-2018 and a 52 week low of Rs. 57.10 on 13-Sep-2017.

Last one week high and low of the scrip stood at Rs. 80.05 and Rs. 67.55 respectively. The current market cap of the company is Rs. 49.86 crore.

The promoters holding in the company stood at 52.17%, while Non-Institutions held 47.82% stake in the company.

Natural Capsules has received in-principle approval for setting up of a Subsidiary Company to be engaged in Research and Development of Nano Medicines and Targeted Drug Delivery System. This will be in participation with a team of dedicated team of Doctors and Scientists spear headed by Dr. Mahesh Rao, Chief Pulmonologist, JSS Hospital Mysuru. The Board of Directors of the company in its meeting on July 30, 2018, approved the same.

Natural Capsules is a well-equipped modern manufacturing plant to manufacture Hard Gelatin Capsule shells, Hard Cellulose Capsule shells and Pharmaceutical Dosage Forms in Capsule Dosage Form.

Natural Capsules Share Price

282.40 -2.30 (-0.81%)
07-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1507.00
Dr. Reddys Lab 6037.55
Cipla 1497.30
Zydus Lifesciences 1058.45
Lupin 1630.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.